452 related articles for article (PubMed ID: 17380207)
1. Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase.
Iwamoto S; Mihara K; Downing JR; Pui CH; Campana D
J Clin Invest; 2007 Apr; 117(4):1049-57. PubMed ID: 17380207
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of asparagine synthetase fails to avert cell cycle arrest induced by L-asparaginase in TEL/AML1-positive leukaemic cells.
Krejci O; Starkova J; Otova B; Madzo J; Kalinova M; Hrusak O; Trka J
Leukemia; 2004 Mar; 18(3):434-41. PubMed ID: 14724653
[TBL] [Abstract][Full Text] [Related]
3. Low expression of asparagine synthetase in lymphoid blasts precludes its role in sensitivity to L-asparaginase.
Hermanova I; Zaliova M; Trka J; Starkova J
Exp Hematol; 2012 Aug; 40(8):657-65. PubMed ID: 22542578
[TBL] [Abstract][Full Text] [Related]
4. Expression levels of ASNS in mesenchymal stromal cells in childhood acute lymphoblastic leukemia.
Dimitriou H; Choulaki C; Perdikogianni C; Stiakaki E; Kalmanti M
Int J Hematol; 2014 Mar; 99(3):305-10. PubMed ID: 24474640
[TBL] [Abstract][Full Text] [Related]
5. Asparagine synthetase expression is linked with L-asparaginase resistance in TEL-AML1-negative but not TEL-AML1-positive pediatric acute lymphoblastic leukemia.
Stams WA; den Boer ML; Holleman A; Appel IM; Beverloo HB; van Wering ER; Janka-Schaub GE; Evans WE; Pieters R
Blood; 2005 Jun; 105(11):4223-5. PubMed ID: 15718422
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of asparagine synthetase expression is not linked to the clinical response L-asparaginase in pediatric acute lymphoblastic leukemia.
Appel IM; den Boer ML; Meijerink JP; Veerman AJ; Reniers NC; Pieters R
Blood; 2006 Jun; 107(11):4244-9. PubMed ID: 16497975
[TBL] [Abstract][Full Text] [Related]
7. Correlation between asparaginase sensitivity and asparagine synthetase protein content, but not mRNA, in acute lymphoblastic leukemia cell lines.
Su N; Pan YX; Zhou M; Harvey RC; Hunger SP; Kilberg MS
Pediatr Blood Cancer; 2008 Feb; 50(2):274-9. PubMed ID: 17514734
[TBL] [Abstract][Full Text] [Related]
8. No evidence of increased asparagine levels in the bone marrow of patients with acute lymphoblastic leukemia during asparaginase therapy.
Tong WH; Pieters R; Hop WC; Lanvers-Kaminsky C; Boos J; van der Sluis IM
Pediatr Blood Cancer; 2013 Feb; 60(2):258-61. PubMed ID: 22961784
[TBL] [Abstract][Full Text] [Related]
9. Utility of
Watanabe A; Miyake K; Yamada Y; Sunamura EI; Yotani T; Kagami K; Kasai S; Tamai M; Harama D; Akahane K; Goi K; Sakaguchi K; Goto H; Kitahara S; Inukai T
Epigenetics; 2023 Dec; 18(1):2268814. PubMed ID: 37839090
[TBL] [Abstract][Full Text] [Related]
10. A new mechanism of leukemia drug resistance?
Williams DA
N Engl J Med; 2007 Jul; 357(1):77-8. PubMed ID: 17611211
[No Abstract] [Full Text] [Related]
11. Tumoral microenvironment prevents de novo asparagine biosynthesis in B cell lymphoma, regardless of ASNS expression.
Grima-Reyes M; Vandenberghe A; Nemazanyy I; Meola P; Paul R; Reverso-Meinietti J; Martinez-Turtos A; Nottet N; Chan WK; Lorenzi PL; Marchetti S; Ricci JE; Chiche J
Sci Adv; 2022 Jul; 8(27):eabn6491. PubMed ID: 35857457
[TBL] [Abstract][Full Text] [Related]
12. Association of aberrant ASNS imprinting with asparaginase sensitivity and chromosomal abnormality in childhood BCP-ALL.
Watanabe A; Miyake K; Nordlund J; Syvänen AC; van der Weyden L; Honda H; Yamasaki N; Nagamachi A; Inaba T; Ikawa T; Urayama KY; Kiyokawa N; Ohara A; Kimura S; Kubota Y; Takita J; Goto H; Sakaguchi K; Minegishi M; Iwamoto S; Shinohara T; Kagami K; Abe M; Akahane K; Goi K; Sugita K; Inukai T
Blood; 2020 Nov; 136(20):2319-2333. PubMed ID: 32573712
[TBL] [Abstract][Full Text] [Related]
13. Sensitivity to L-asparaginase is not associated with expression levels of asparagine synthetase in t(12;21)+ pediatric ALL.
Stams WA; den Boer ML; Beverloo HB; Meijerink JP; Stigter RL; van Wering ER; Janka-Schaub GE; Slater R; Pieters R
Blood; 2003 Apr; 101(7):2743-7. PubMed ID: 12433682
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms of asparaginase pathway and asparaginase-related complications in children with acute lymphoblastic leukemia.
Ben Tanfous M; Sharif-Askari B; Ceppi F; Laaribi H; Gagné V; Rousseau J; Labuda M; Silverman LB; Sallan SE; Neuberg D; Kutok JL; Sinnett D; Laverdière C; Krajinovic M
Clin Cancer Res; 2015 Jan; 21(2):329-34. PubMed ID: 24907114
[TBL] [Abstract][Full Text] [Related]
15. The glutaminase activity of L-asparaginase is not required for anticancer activity against ASNS-negative cells.
Chan WK; Lorenzi PL; Anishkin A; Purwaha P; Rogers DM; Sukharev S; Rempe SB; Weinstein JN
Blood; 2014 Jun; 123(23):3596-606. PubMed ID: 24659632
[TBL] [Abstract][Full Text] [Related]
16. A genome-wide view of the in vitro response to l-asparaginase in acute lymphoblastic leukemia.
Fine BM; Kaspers GJ; Ho M; Loonen AH; Boxer LM
Cancer Res; 2005 Jan; 65(1):291-9. PubMed ID: 15665306
[TBL] [Abstract][Full Text] [Related]
17. [Relationship between asparagine synthetase expression level and cell sensitivity to L-asparaginase in human leukemic cell lines].
Li BS; He YY; Luo CY; Jiang H; Shen SH; Jiang LM; Zhang B; Gu LJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):559-63. PubMed ID: 20561401
[TBL] [Abstract][Full Text] [Related]
18. Association of allele-specific methylation of the ASNS gene with asparaginase sensitivity and prognosis in T-ALL.
Akahane K; Kimura S; Miyake K; Watanabe A; Kagami K; Yoshimura K; Shinohara T; Harama D; Kasai S; Goi K; Kawai T; Hata K; Kiyokawa N; Koh K; Imamura T; Horibe K; Look AT; Minegishi M; Sugita K; Takita J; Inukai T
Blood Adv; 2022 Jan; 6(1):212-224. PubMed ID: 34535013
[TBL] [Abstract][Full Text] [Related]
19. Asparagine synthetase (ASNS) gene polymorphism is associated with the outcome of childhood acute lymphoblastic leukemia by affecting early response to treatment.
Pastorczak A; Fendler W; Zalewska-Szewczyk B; Górniak P; Lejman M; Trelińska J; Walenciak J; Kowalczyk J; Szczepanski T; Mlynarski W;
Leuk Res; 2014 Feb; 38(2):180-3. PubMed ID: 24268318
[TBL] [Abstract][Full Text] [Related]
20. Synergistic Cytotoxic Effect of L-Asparaginase Combined with Decitabine as a Demethylating Agent in Pediatric T-ALL, with Specific Epigenetic Signature.
Serravalle S; Bertuccio SN; Astolfi A; Melchionda F; Pession A
Biomed Res Int; 2016; 2016():1985750. PubMed ID: 28003999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]